Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Update

Vyome Holdings, Inc. (NASDAQ:HIND) was the recipient of a large decrease in short interest in June. As of June 30th, there was short interest totaling 35,140 shares, a decrease of 45.9% from the June 15th total of 64,989 shares. Approximately 0.7% of the shares of the company are short sold. Based on an average trading volume of 20,610 shares, the short-interest ratio is currently 1.7 days.

Institutional Trading of Vyome

A hedge fund recently bought a new position in Vyome stock. Millennium Management LLC acquired a new position in shares of Vyome Holdings, Inc. (NASDAQ:HIND) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 45,144 shares of the company’s stock, valued at approximately $155,000. Millennium Management LLC owned approximately 0.80% of Vyome at the end of the most recent reporting period. 22.06% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on HIND shares. Zacks Research raised Vyome to a “hold” rating in a report on Wednesday, May 6th. Weiss Ratings upgraded Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research note on Friday, May 1st. Finally, Litchfield Hills Research started coverage on Vyome in a research report on Monday, May 4th. They issued a “buy” rating for the company. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $15.00.

Vyome Stock Down 2.7%

NASDAQ HIND opened at $2.18 on Wednesday. Vyome has a twelve month low of $1.75 and a twelve month high of $18.60. The stock has a market cap of $15.30 million, a P/E ratio of -0.18 and a beta of 1.49. The company’s 50-day simple moving average is $2.17 and its 200 day simple moving average is $2.48.

Vyome (NASDAQ:HIND) last released its quarterly earnings data on Tuesday, May 12th. The company reported ($0.15) earnings per share for the quarter. The business had revenue of $0.03 million during the quarter. Research analysts anticipate that Vyome will post -0.6 earnings per share for the current year.

Vyome Company Profile

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.